Skip to main content
An official website of the United States government

autologous gene-modified PD-1-positive T lymphocytes ScTIL210

A preparation of autologous programmed cell death protein 1 (PD-1; PDCD1; CD279)-positive T lymphocytes transduced with a lentiviral vector encoding for an as of yet undisclosed receptor, with potential immunomodulating activity. Upon administration, autologous gene-modified PD-1-positive T lymphocytes ScTIL210 may recognize and kill the patient's tumor cells through as of yet not elucidated receptor binding.
Synonym:autologous gene-modified PD-1-positive T cells ScTIL210
Code name:ScTIL 210
ScTIL-210
ScTIL210
Search NCI's Drug Dictionary